Biolase, Inc. · OTC:BIOLQ
Biolase — 29th Annual ROTH Conference 2017
26 slides from Biolase's conference presentation, Mar 14, 2017
Slide 1: World Leader in Dental Lasers
World Leader in Dental Lasers Transformational Technology Enabling Better Patient Outcomes NASDAQ CM:BIOL 29th Annual ROTH Conference, March 12-15, 2017 Exhibit 99.1
Slide 2: Safe Harbor Statement
Statements made during BIOLASE’s presentation and investor meetings at the 29th Annual ROTH Conference, March 12-15, 2017 (the “Meetings”), and its representative’s answers to questions that refer to BIOLASE’s estimated or anticipated future results or other non-historical facts are forward-looking
Slide 3: Investment Thesis
Disrupting Dentistry Through Transformational Laser Technology and Products, World-class Education: Turnaround – continuing revenue and profit growth with focus on commercial execution, international performance/expansion, superlative education Strategic pivot to focus on high-value, prevalent and u
Slide 4: Experienced Leadership Team Enables Continued Progress and Transformation of BIOLASE
Experienced Leadership Team Enables Continued Progress and Transformation of BIOLASE Harold C. Flynn, Jr. President & CEO Mark Nelson Chief Financial Officer (Starts 3/27/17) Michael Roux Vice President, Marketing Dmitri Boutoussov Chief Technology Officer Richard Whipp Vice President, Operations Jo
Slide 5: Leadership broad experience in dentistry, medical lasers and medical devices
Broad experience in dentistry, medical lasers, medical device and pharma companies; from start-ups to Fortune 100 companies New CEO, July 2015; Led Zimmer Dental for eight years Introduced transformational products; developed world’s leading dental regenerative portfolio Executed international M&A;
Slide 6: High Level Plan
High Level Plan Key Strategic Priorities Goals Build Talent & Team, Shape Healthy High-Performance Culture Drive Commercial Execution & Channel Excellence US EMEA ROW Delight the customer – customer service build out and support excellence Elevate Training and Education & Educator/Opinion Leader sta
Slide 7: 3 Imperatives to Disrupt Dentistry
BREAK THE STATUS QUO - Get dentists around the world to perform procedures with lasers that they may be afraid of doing and uncomfortable presenting(selling) to patients…help make every dentist a better dentist EDUCATE TO HIGH COMPETENCE - Ensure great results with simple to use and versatile system
Slide 8: Laser Dentistry Addresses Challenges Facing Today's Dentists
Laser Dentistry Addresses Challenges Facing Today’s Dentists as Described by the ADA, CDC, Other Professional Organizations Seeking Better Patient Reported Outcomes With More Competition, Less Busy and Become Bored Missing Opportunity To Treat Earlier and Make More Money Average Pay Decreasing Over
Slide 9: More Than 60,000,000 People Have Gum Disease
More Than 60,000,000 People Have Gum Disease, and Health Risk of Oral-systemic Connection in U.S. Alone Waterlase iPlus Home Screen Significant Growth Opportunity Under-diagnosed, Under-treated, Under-managed
Slide 10: Patients Above All Else
Patients Above All Else Increased Health Healing Esthetics Tooth preservation Decreased Anesthetic Scars Discomfort Fear Trauma Our Lasers Deliver an Entirely New Patient Experience with Increased Comfort – and Less of the Anxiety and Pain Ordinary Dentistry Can Cause
Slide 11: Serving Clinicians – Better Dentistry, Better Business
Serving Clinicians – Better Dentistry, Better Business Increased Positive outcomes Patient excitement Healing Local market buzz Cash flow Decreased Complications Anxiety Chair time Procedure-based Laser Solutions Enable Professional and Practice Growth Globally
Slide 12: Positive Cash Flow – Investment in Patient Outcomes and Business Returns
Positive Cash Flow – Investment in Patient Outcomes and Business Returns WL Express Lease Cost: $840/Month New Procedures (of dozens available) & Representative Fee/Reimbursement Avg. (net of consumable cost) No./ ProcedureNet Month Total Crown Lengthening$525 1 $525 Perio (1-3 teeth)$350 2 $700 Gin
Slide 13: A Growing Full-spectrum Portfolio of Laser Systems
New! – Most powerful and capable diode dental laser ever Best in class speed, comfort, and precision cutting Leverages IPG Medical technology A Growing Full-spectrum Portfolio of Laser Systems and Procedural Consumables New! – Smallest, easiest most cost-effective Waterlase Vivid HD tablet user inte
Slide 14: Waterlase Express Exclusive Integrated Learning
Full on-board library of 4K animations Developed by leading laser experts Simpler learning Visual training Easier selling Waterlase Express’s Exclusive Integrated Learning 120 individual procedure animations to educate and ensure routine use
Slide 15: Poised to Cross The Chasm in All-Tissue Laser Adoption
Moving to a “Whole Product” approach to successfully address Pragmatists Differentiated “value tiered” product portfolio to access and expand more markets Pivoting strategy to widely prevalent yet under-treated diseases Development of alternative business models and pricing strategies BIOLASE Poised
Slide 16: U.S. Dental Market Opportunity for All-Tissue Lasers
The U.S. Dental Market has Significant Remaining Opportunity for All-Tissue Lasers to Penetrate Clinics Improved Patient Reported Outcomes High prevalence, under-treated conditions High Volume Procedures THE OPPORTUNITY ADDRESSABLE MARKET TARGET MARKET SERVED UNSERVED 97,009 72,758 6,700 66,058 75%
Slide 17: Global All-Tissue Penetration at ~5%
Global All-Tissue Penetration at ~5% Reinforces “The Chasm” Not Yet Crossed to the Early Majority – Significant Opportunity Exists High Volume Procedures Improved Clinical Outcomes Evidence-based THE OPPORTUNITY ADDRESSABLE MARKET TARGET MARKET SERVED UNSERVED 606,116 403,678 18,200 385,477 Sources:
Slide 18: Dominant Share in All-Tissue Laser Markets
BIOLASE Positioned Well with Dominant Share in All-Tissue Laser Markets and Market Leadership in Soft-Tissue Lasers Soft Tissue Lasers Global Share All Tissue Lasers Global Share The majority of lasers sold are Soft Tissue devices. However, Biolase commands a dominant or significant share in both ma
Slide 19: Historical Market Revenue Trends and BIOLASE CAGR Potential
Historical Market Revenue Trends Achieved Mid to High Single Digit CAGR – BIOLASE Can Achieve >15% CAGR Over Next 5 Years (000s) Sources: iData Research 2014 reports; MarketMarkets Research 2015; industry and anecdotal reports. All Tissue Laser Market - Global Soft Tissue Laser Market - Global Total
Slide 20: 2016 Revenue by Laser System Sales and Geography
More Than Two Thirds of 2016 Revenue Came from Laser System Sales, 64% of Sales Were Made in U.S. United States 64% International 36% Significant Opportunity in Bringing Europe “On Par” with U.S.
Slide 21: Financial Highlights: Selected Income Statement Data
($ in Thousands) Q4 2016 Q4 2015 % Delta 2016 (Audited) 2015 (Audited) % Delta Net Revenue $ 13,761 $ 14,517 -5.0 $ 51,810 $ 48,475 6.9 Cost of Revenue 8,358 8,859 -5.7 31,502 32,525 -3.2 Gross Profit 5,403 5,658 -4.5 20,308 15,950 27.4 Total Operating Expenses 9,517 7,933 20.0 35,270 35,865 -1.7 GA
Slide 22: Financial Highlights: Selected Balance Sheet Data
($ in Thousands) 12/31/2016 (Audited) 12/31/2015 (Audited) Change % Cash & Cash Equivalents $ 8,924 $ 11,699 $ (2,775) -23.8 Accounts Receivable 9,784 8,948 836 9.3 Inventory 13,523 12,566 957 7.6 Total Current Assets $ 33,987 $ 34,800 $ (813) -2.3 Total Assets $ 41,941 $ 42,251 $ (310) -.07 Total C
Slide 23: BIOLASE Stock Data
BIOLASE Stock Data: (NASDAQ:BIOL) - 1 Year 52 Week Price Range $0.80 - $1.98 Recent Price (March 9, 2017) $1.20 Average Daily Volume (3 month) 171,823 Common Shares Outstanding (January 5, 2017) 67,565,951 Market Capitalization (March 9, 2017) $81,079,141
Slide 24: Summary
World leader in dental laser systems having sold ~33,600 dental laser systems Veteran top management team with successful dental industry and medical device experience leading the turnaround and transformation of BIOLASE Disrupting dentistry establishing new standards of care for under-managed disea
Slide 25: Questions and Answers
Questions and Answers BIOLASE
Slide 26: World Leader in Dental Lasers
World Leader in Dental Lasers Transformational Technology Enabling Better Patient Outcomes NASDAQ CM:BIOL 29th Annual ROTH Conference, March 12-15, 2017